Table 1 Univariant analysis of the influence of NEO-FFI personality dimensions on skipping TKI doses during the entire treatment period in a group of chronic myeloid leukemia patients (n = 140)
Variable | Patients who reported dose skipping (n = 72) | Patients who did not report dose skipping (n = 68) | t | df | P value | ||
|---|---|---|---|---|---|---|---|
M | SD | M | SD | ||||
NEO-FFI Neuroticism | 19.4 | 7.4 | 17.9 | 6.7 | 1.28 | 138 | 0.201 |
NEO-FFI Extraversion | 28.5 | 7.2 | 28.3 | 6.4 | 0.14 | 138 | 0.891 |
NEO-FFI Openess | 24.9 | 6.4 | 24.3 | 6.0 | 0.56 | 138 | 0.580 |
NEO-FFI Agreeableness | 32.8 | 6.7 | 33.5 | 5.2 | -0.73 | 138 | 0.466 |
NEO-FFI Conscientiousness | 36.4 | 6.7 | 36.1 | 5.8 | 0.29 | 138 | 0.774 |